JOSE MIGUEL
MONTEJO BARANDA
Investigador/a en el periodo 1993-2019
Corporació Sanitària Parc Taulí
Barcelona, EspañaPublicaciones en colaboración con investigadoras/es de Corporació Sanitària Parc Taulí (6)
2017
-
Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088
-
HIV type 2 epidemic in Spain: Challenges and missing opportunities
AIDS, Vol. 31, Núm. 10, pp. 1353-1364
-
High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2102-2109
2015
2014
-
Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin
Journal of Antimicrobial Chemotherapy
-
Lack of association between genotypes and haematogenous seeding infections in a large cohort of patients with methicillin-resistant Staphylococcus aureus bacteraemia from 21 Spanish hospitals
Clinical Microbiology and Infection, Vol. 20, Núm. 4, pp. 361-367